Cognizant selected as technology provider for Fortrea’s transformation initiative

Cognizant and Fortrea, a provider of clinical development and patient access solutions in the life sciences industry, has announced a new partnership. Under this agreement, Cognizant will be the strategic technology transformation provider for Fortrea, focusing on enhancing its digital infrastructure and services.

This four-year collaboration is set to transform Fortrea’s global technology environment. Cognizant’s role will involve deploying advanced hybrid cloud technologies and platforms, and is expected to boost Fortrea’s data and analytical capabilities as well.

The partnership comes after Fortrea’s spin-off from its parent company in June 2023, a strategic move to increase its agility and growth in areas like clinical trials and patient access, particularly in oncology and clinical pharmacology. Cognizant will assist in transitioning Fortrea away from its former parent company’s Transition Service Agreements, setting up a new global infrastructure for Fortrea, including application management and end-user services.

[Image courtesy: Fortrea]

Just in

Mizuho, IBM develop AI system for banking error detection

Mizuho and IBM have collaborated to develop a proof of concept (PoC) system that utilizes watsonx, IBM's enterprise generative AI and data platform, to enhance the efficiency and accuracy of Mizuho's event detection operations.

Lumos raises $35M

San Francisco, CA-based access management platform provider Lumos has raised $35 million in Series B financing.

Aerodome raises $21.5M

Aerodome, a Los Angeles, CA-based company specializing in Drone-As-First-Responder (DFR) technology, has secured $21.5 million in a Series A funding round.

Uncle Sam to inject $50M into auto-patcher for hospital IT — The Register

The US government's Advanced Research Projects Agency for Health (ARPA-H) has pledged more than $50 million to fund the development of technology that aims to automate the process of securing hospital IT environments, writes Jessica Lyons in The Register.